<p>Patients’ Perceptions and Preferences Regarding Two Different Forms of Methotrexate Autoinjectors for Moderate to Severe Rheumatoid Arthritis: A European Crossover Survey</p>
نویسندگان
چکیده
منابع مشابه
Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe
INTRODUCTION Benepali® was the first etanercept (Enbrel®) biosimilar to be approved in the European Union. Both Benepali and Enbrel are available as autoinjector devices. In a recent survey, nurses from France, Germany, Italy, Spain, and the United Kingdom (UK) reported that their patients with rheumatoid arthritis (RA) would prefer the Benepali autoinjector compared to the Enbrel MYCLIC autoin...
متن کاملPerceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
INTRODUCTION Enbrel® (etanercept: manufactured by Immunex Corporation, Newbury Park, Thousand Oaks, CA 91320, USA) was the first biological disease-modifying anti-rheumatic drug approved for the treatment of rheumatoid arthritis (RA) in Europe. More recently, an etanercept biosimilar (Benepali®: manufactured by Biogen Inc, Cambridge, MA 02124, USA) was approved in the European Union. The percep...
متن کاملassociation between rheumatoid arthritis and moderate to severe periodontitis in iranian adults
objective: periodontal diseases are common in the society and some researchers suggested an association between rheumatoid arthritis (ra) and periodontal diseases. the present study was carried out to evaluate the so-called association in iranian adults. materials and methods: in this case-control study, the samples were recruited from patients referred to loghman hospital, tehran, during 2004-...
متن کاملPatient Preferences Regarding Rheumatoid Arthritis Therapies: A Conjoint Analysis.
BACKGROUND Tofacitinib, an oral Janus kinase inhibitor approved for the treatment of rheumatoid arthritis (RA), provides patients with an alternative to subcutaneously or intravenously administered biologic disease-modifying antirheumatic drugs (DMARDs). Little is known about patient preference for novel RA treatments. OBJECTIVE To investigate patient preferences for attributes associated wit...
متن کاملErratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Among the nine nurses who indicated a preference for the Enbrel MYCLIC autoinjector, the most common reasons given were ‘‘easy to operate’’ (n = 6), followed by ‘‘easy to grip’’ (n = 5), ‘‘audible feedback’’ (n = 4), and ‘‘concealing the injection needle’’ (n = 4) (Fig. 5). Open Access. This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 Internationa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Patient Preference and Adherence
سال: 2020
ISSN: 1177-889X
DOI: 10.2147/ppa.s269575